Your session is about to expire
← Back to Search
BCI-FIT for ALS (BCI-FIT Trial)
BCI-FIT Trial Summary
This trial is testing a new brain-computer interface (BCI) that does not require surgery for people with severe speech and physical impairments. The goal is to improve communication for people with these impairments.
BCI-FIT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBCI-FIT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BCI-FIT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- "Controls" typically refers to a group of participants in a study who do not receive the treatment being tested, serving as a comparison for the group receiving the treatment.You have severe difficulty speaking or moving, or have certain types of implanted medical devices.People with severe difficulty speaking or moving, who may be at risk of skin problems from touching the study equipment.I can select and copy letters, words, or icons well enough to communicate.You have severe difficulty speaking or moving, but you are expected to live for more than 6 months.I have a severe condition affecting my speech and movement.I have been hospitalized multiple times in the last 6 weeks due to unstable health.I am an adult between 18-89 with severe speech and physical impairments.I have a condition like muscular dystrophy, ALS, or Parkinson's that affects my brain or muscles.I live within 2 hours of OHSU or can travel there.Despite my severe speech and physical impairments, I can attend study visits for 1-3 hours.You are expected to live for at least 6 more months.I can attend study visits that last between 1 to 3 hours.I can attend study visits that last 1-3 hours.I can select letters or icons to communicate despite my severe speech and physical impairments.I have a condition that causes seizures triggered by lights.I can read and communicate in English, even with speech or physical challenges.
- Group 1: Language modeling
- Group 2: Active querying techniques
- Group 3: BCI-FIT multi-modal configuration
- Group 4: Adaptive signal modeling
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experiment permit individuals above thirty years old to participate?
"This research study mandates that all participants are between 18 and 89 years old. Separately, there are 134 studies for minors and 995 for those over 65."
Who is most suited to participate in this medical experiment?
"This clinical trial is recruiting a cohort of 60 adults aged between 18 and 89 to study multiple system atrophy. Qualifying patients must be able to communicate in English, dedicate 1-3 hours for each visit with the research team, have been diagnosed with certain degenerative or neurodevelopmental conditions (e.g., Duchenne muscular dystrophy, Rett Syndrome etc.), live within 2 hour drive from OHSU or agree to travel there, and possess sufficient visuospatial skills needed to select letters/words/icons as part of their participation."
Is the enrollment process for this trial still open?
"According to clinicaltrials.gov, this research endeavour remains in its participant recruitment phase. The trial was first declared on July 15th 2022 and has received revisions as recently as September 7th of the same year."
How many individuals are currently being recruited for this experiment?
"Affirmative. As per the information found on clinicaltrials.gov, this research study is actively enrolling individuals with its initial post marked July 15th 2022 and most recent update made September 7th 2022. This trial requires 60 participants to be recruited from 1 site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger